AstraZeneca could pay Daiichi Sankyo up to $6.9 billion in cancer drug deal

AstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daiichi’s cancer drug trastuzumab deruxtecan that could see the British drugmaker pay as much as $6.9 billion to its Japanese partner.

…read more

Read more here: AstraZeneca could pay Daiichi Sankyo up to $6.9 billion in cancer drug deal

Category: businessNews

Leave a Reply

%d bloggers like this: